# Intermittent Preventive Treatment for Malaria in Patient With Sickle Cell Disease

> **NCT01319448** · PHASE1,PHASE2 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 270 (actual)

## Conditions studied

- Malaria
- Sickle Cell Crisis

## Interventions

- **DRUG:** Proguanil
- **DRUG:** mefloquine plus artesunate
- **DRUG:** Sulfadoxine-pyrimethamine plus amodiaquine

## Key facts

- **NCT ID:** NCT01319448
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2014-03-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01319448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01319448, "Intermittent Preventive Treatment for Malaria in Patient With Sickle Cell Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01319448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*